Cargando…

Review time of oncology drugs and its underlying factors: an exploration in China

Introduction: How the launch delay of drugs and other factors of interest can influence the length of the review period by drug agencies is still unknown, and understanding this can help better strike the trade-off related to review speed. Methods: We included all new oncology drug applications subm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xingyue, Liu, Bao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654631/
https://www.ncbi.nlm.nih.gov/pubmed/38027001
http://dx.doi.org/10.3389/fphar.2023.1151784

Ejemplares similares